Hansen Medical®, Inc., the global leader in intravascular robotics, today announced the completion of the first clinical procedure in the United States with the Magellan™ Robotic Catheter eKit (MRC eKit). Interventional Radiologist, Dr. Ripal Gandhi, performed the procedure at Miami Cardiac & Vascular Institute (MCVI) in Miami, FL. Dr. Gandhi used the MRC eKit during a robotic transarterial chemoembolization (TACE) procedure.
The Magellan Robotic Catheter eKit is the company's latest addition to the family of approved Magellan Robotic Catheters and helps extend robotic capabilities and control throughout procedures in the peripheral vasculature. With the MRC eKit, physicians now have robotic control of 3rd party microcatheters through the existing Magellan Robotic Catheter 6Fr architecture. This added ability has the potential to help reduce procedure times and radiation exposure. Hansen Medical received FDA Approval for this device earlier this month.
"We were able to reach several targets within the liver during today's chemoembolization procedure to successfully deliver therapy using the Magellan Robotic Catheter eKit," said Gandhi. "We experienced added stability and control of our smaller microcatheters, which added to the level of precision during the procedure. With the MRC eKit, we were also able to confidently do a significant portion of the procedure away from the radiation source and feel that this is a significant step in reducing radiation exposure during interventional procedures."
"Congratulations to Dr. Gandhi and Miami Cardiac & Vascular Institute on successfully completing the first procedure with the Magellan Robotic Catheter eKit in the United States," said Cary Vance, Chief Executive Officer of Hansen Medical. "We value our partnership with Dr. Gandhi and MCVI and commend their ongoing efforts to advance the application of robotic technology in the endovascular space, including the treatment of cancer," continued Vance.
The Magellan Robotic System is an advanced technology that drives Magellan Robotic Catheters and guide wires during minimally-invasive, endovascular procedures. Magellan is designed to offer procedural predictability, precision, and catheter stability as physicians navigate inside blood vessels and deliver therapy. Image-guided medical procedures using interventional fluoroscopy, while growing rapidly, are the leading source of occupational ionizing radiation exposure for medical personnel. Magellan's remote workstation allows physicians to control robotic catheters and guide wires while seated away from the radiation field, which has been shown to reduce radiation exposure for the physician by as much as 95% in complex endovascular procedures.